Current Infectious Disease Reports

ISSN: 1523-3847

Journal Home

Journal Guideline

Current Infectious Disease Reports Q2 Unclaimed

Current Science, Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Infectious Disease Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of infectious disease. Offers the views of experts on current advances in the infectious disease field Highlights the most important recent papers from a wealth of original publications Also provides supplementary reviews featuring recently published clinical trials, valuable web sites, and commentaries from well-known figures in the field It has an SJR impact factor of 0,97.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3060 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Current Infectious Disease Reports

0,97

SJR Impact factor

54

H Index

19

Total Docs (Last Year)

114

Total Docs (3 years)

1495

Total Refs

422

Total Cites (3 years)

114

Citable Docs (3 years)

3.34

Cites/Doc (2 years)

78.68

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Impact of antimicrobial resistance on the treatment of invasive pneumococcal infections

View more

Management of antiretroviral therapy in neonates, children, and adolescents

View more

The Importance of Colonization with Clostridium difficile on Infection and Transmission

View more

Health Care-Associated Infective Endocarditis: a Growing Entity that Can Be Prevented

View more

African trypanosomiasis: Changing epidemiology and consequences

View more

Does lactobacillus prevent post-antibiotic vulvovaginal candidiasis?

View more

New insights on interactions between HIV-1 and HSV-2

View more

Pharmacologic aspects of new antiretroviral drugs

View more

Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection

View more

Estrogen replacement therapy to prevent recurrent urinary tract infection in postmenopausal women

View more

New biomedical strategies for HIV-1 prevention in women

View more

New fluoroquinolones: Real and potential roles

View more
SHOW MORE ARTICLES

Immune restoration inflammatory syndromes: The dark side of successful antiretroviral treatment

View more

Health Considerations for HIV-Infected International Travelers

View more

What Is New in Antibiotic Therapy in Community-Acquired Pneumonia? An Evidence-Based Approach Focusing on Combined Therapy

View more

Management of HIV infection in patients with substance use problems

View more

Mucormycosis of the Head and Neck

View more

When to Start Antiretroviral Therapy

View more

HIV, Sexually Transmitted Infections, and Sexuality in Later Life

View more

Optimal management of uncomplicated skin and skin structure infections of the lower extremity

View more

Duration of antibiotic treatment for urinary tract infection

View more

Azithromycin versus penicillin in acute group A streptococcal tonsillopharyngitis

View more

Adjunctive therapies in severe sepsis and septic shock: Current place of steroids

View more

Azole Antifungal Resistance Today: Focus on Aspergillus

View more

FAQS